Newleos Therapeutics Funding: $93M Raised, Series A (2025)
Newleos Therapeutics is a Biotech company based in Boston. It has raised $93M in total funding. Latest round: Series A.
Newleos Therapeutics funding overview
Newleos Therapeutics is a Biotech company based in Boston. Newleos Therapeutics has raised $93M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2025. The round record for Newleos Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Goldman Sachs Alternatives, Longwood Fund. 2 distinct backers are named across the disclosed rounds.
Newleos Therapeutics at a glance
Total raised
$93M
Latest round
Series A
Latest round date
February 2025
Industry
Biotech
Headquarters
Boston
Notable investors
Goldman Sachs Alternatives, Longwood Fund
Frequently asked about Newleos Therapeutics funding
How much has Newleos Therapeutics raised?
Newleos Therapeutics has raised $93M in total disclosed funding across the rounds on record.
Who has invested in Newleos Therapeutics?
Goldman Sachs Alternatives, Longwood Fund are named among the investors backing Newleos Therapeutics.
What was the latest Newleos Therapeutics funding round?
The most recent disclosed round is a Series A, announced in February 2025.
Where is Newleos Therapeutics based?
Newleos Therapeutics is based in Boston.
What sector does Newleos Therapeutics operate in?
Newleos Therapeutics is tracked under Biotech from Boston, with $93M in disclosed funding.
When did Newleos Therapeutics last raise?
The last disclosed Newleos Therapeutics round closed in February 2025 at Series A.
Totals shown for Newleos Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
